A study listed on ClinicalTrials.gov.
- Who can join
- Adults 40 to 59, women only, have obesity or are overweight, BMI 27+.
- What you take
- Check ClinicalTrials.gov for this trial's study groups and what each group receives.
- How long it lasts
- The study runs about 7 months.
- What you get
- Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
What this study is for
Primary condition: Women's Health. Also studied in: Obesity & Overweight, Perimenopausal Women, Digital Intervention, Behavior Change, glp1 Agonist, Resistance Exercise.
Full scientific study title: Digital Resistance Training for Midlife Women Using GLP-1.
Who can join
Adults 40 to 59, women only, have obesity or are overweight, BMI 27+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.
Full medical eligibility (for you and your doctor)verbatim from the registry
This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.
Key inclusion criteria
- Female, age 40 to 54 years.
- Recently initiated GLP-1 receptor agonist (GLP-1RA) therapy within the past 6 months.
- Body mass index (BMI) ≥27 kg/m².
- Not currently participating in regular resistance training (self-reported absence of regular resistance training during the previous month).
- Able to stand, sit, and perform bodyweight movements without assistive devices.
Key exclusion criteria
- Plans to discontinue GLP-1RA therapy or substantially modify treatment during the 12-week study period.
- Self-reported musculoskeletal injury, orthopedic limitation, or surgery within the previous 6 months that would contraindicate resistance training participation.
- Self-reported unstable cardiovascular disease or cardiac event within the previous 6 months.
- Currently pregnant or planning to become pregnant during the study period.
- Active eating disorder or psychiatric condition that may interfere with study participation.
Where this trial runs
This trial has 1 sites across 1 state. Site contacts are listed for reference. They are not screening through this trial right now.
Louisiana1 site
- Louisiana State University School of KinesiologyBaton Rouge, Louisiana
Timeline
Scheduled start: November 1, 2026. Expected completion: June 30, 2027. Last updated on ClinicalTrials.gov: August 26, 2026.
Official source
Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:
Other GLP-1 clinical trials
Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.
